Oral administration of red ginseng acidic polysaccharide (RGAP) dose-dependently upregulates the LPL activity of hyperlipidemia rats and reduces the level of TG to regulate the hyperlipidemia state of rats [19]. Here, LPL is linked to hyperlipidemia.